Veronique L. Konijn
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells.
Journal: Journal of virology
Published: July 29, 2026
Combining Activation-Induced Markers With PD-L1 Selectively Enhances Detection of Antigen-Specific T Cells in Virus-Infected Individuals.
Journal: Journal of immunology research
Published: June 20, 2025
Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T-Cell Epitopes.
Journal: Bioconjugate chemistry
Published: November 08, 2024
Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8+ T Cell Responses.
Journal: European journal of immunology
Published: October 10, 2024
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection.
Journal: Frontiers in immunology
Published: October 03, 2024
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 14, 2023
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 18, 2022
IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
Journal: Experimental dermatology
Published: June 10, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026